Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin

BACKGROUND: Doxil(®) (PEGylated liposomal doxorubicin, PLD) has been widely used in cancer treatment due to its excellent therapeutic efficacy, but it can simultaneously cause severe adverse effects such as hand-foot syndrome (HFS). To date, the pathophysiologic mechanism of HFS development induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaolin, Dong, Mengmeng, Liang, Xiao, Liu, Ziling, Li, Quanshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822082/
https://www.ncbi.nlm.nih.gov/pubmed/33500617
http://dx.doi.org/10.2147/IJN.S280187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822082/
https://www.ncbi.nlm.nih.gov/pubmed/33500617
http://dx.doi.org/10.2147/IJN.S280187

Ejemplares similares